Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study
- PMID: 20042102
- PMCID: PMC2806311
- DOI: 10.1186/1477-7827-7-153
Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study
Abstract
Background: Our objective was to investigate luteinizing hormone, follicle-stimulating hormone, testosterone, and androstenedione as predicitve markers for ovulation after laparoscopic ovarian drilling.
Methods: We retrospectively analyzed 100 clompihen-resistant patients with the polycystic ovary syndrome who underwent laparoscopic ovarian drilling at our department. The main outcome measure was spontaneous postoperative ovulation within three months after laparoscopic ovarian drilling. In order to predict spontaneous ovulation, we tested the following parameters by use of a univariate followed by a multivariate regression model: Preoperative serum levels of LH, FSH, testosterone, and androstenedione as well as patients' age and body mass index. In addition, we focused on pregnancy and life birth rates.
Results: Spontaneous ovulation was documented in 71/100 patients (71.0%). In a univariate and multivariate analysis, luteinizing hormone (OR 1.58, 95%CI: 1.30-1.92) and androstenedione (OR 3.03, 95%CI: 1.20-7.67), but not follicle-stimulating hormone and testosterone were independent predictors of ovulation. Using a cut-off for luteinizing hormone and androstenedione of 12.1 IU/l and 3.26 ng/ml, respectively, spontaneous ovulation was observed in 63/70 (90.0%) and 36/42 patients (85.7%) with elevated and in 8/30 (26.7%) and 35/58 (60.3%) patients with low luteinizing hormone and androstenedione levels, respectively. The sensitivity, specificity, positive and negative predictive values for luteinizing hormone and androstendione as predictors of spontaneous ovulation after ovarian drilling were 88.7% (95%CI: 79.0-95.0%), 75.9% (95%CI: 56.5-89.7%), 90.0% (95%CI: 80.5-95.8%), and 73.3% (95%CI: 54.1-87.7%) for luteinizing hormone, and 50.7% (95%CI: 38.6-62.8%), 79.3% (95%CI: 60.3-92.0%), 85.7% (95%CI: 71.5-94.6%), and 39.7% (95%CI: 27.0-53.4%) for androstenedione, respectively. Complete one-year follow-up was available for 74/100 patients (74%). We observed a one-year pregnancy rate and a resulting life-birth rate of 61% and 51%, respectively.
Conclusions: Luteinizing hormone and androstenedione prior to laparoscopic ovarian drilling are independent predictors of spontaneous ovulation within three months of surgery. We suggest to preferentially performing laparoscopic ovarian drilling in patients with high luteinizing hormone and androstenedione levels.
Similar articles
-
Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:126-133. doi: 10.1016/j.ejogrb.2018.01.011. Epub 2018 Feb 3. Eur J Obstet Gynecol Reprod Biol. 2018. Retraction in: Eur J Obstet Gynecol Reprod Biol. 2024 Oct;301:180. doi: 10.1016/j.ejogrb.2024.07.053. PMID: 29408743 Retracted.
-
Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:178-85. doi: 10.1016/j.ejogrb.2014.01.016. Epub 2014 Jan 20. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24576485 Clinical Trial.
-
Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.Gynecol Endocrinol. 1996 Aug;10(4):257-64. doi: 10.3109/09513599609012317. Gynecol Endocrinol. 1996. PMID: 8908526
-
Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials.Arch Gynecol Obstet. 2018 Apr;297(4):859-870. doi: 10.1007/s00404-018-4680-1. Epub 2018 Jan 27. Arch Gynecol Obstet. 2018. PMID: 29374790 Review.
-
Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.Semin Reprod Med. 2011 Mar;29(2):138-46. doi: 10.1055/s-0031-1272476. Epub 2011 Mar 24. Semin Reprod Med. 2011. PMID: 21437828 Review.
Cited by
-
Is There Still a Place for Surgery in Patients with PCOS? A Review.Life (Basel). 2023 May 28;13(6):1270. doi: 10.3390/life13061270. Life (Basel). 2023. PMID: 37374053 Free PMC article. Review.
-
Perioperative androstenedione kinetics in women undergoing laparoscopic ovarian drilling: a prospective study.Endocrine. 2014 Dec;47(3):936-42. doi: 10.1007/s12020-014-0267-1. Epub 2014 Apr 17. Endocrine. 2014. PMID: 24740546
-
Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate.Eur J Obstet Gynecol Reprod Biol X. 2019 Aug 13;4:100093. doi: 10.1016/j.eurox.2019.100093. eCollection 2019 Oct. Eur J Obstet Gynecol Reprod Biol X. 2019. PMID: 31497757 Free PMC article.
-
Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome.J Nat Sci Biol Med. 2015 Jan-Jun;6(1):40-8. doi: 10.4103/0976-9668.149076. J Nat Sci Biol Med. 2015. PMID: 25810633 Free PMC article. Review.
References
-
- Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2002;78:404–411. doi: 10.1016/S0015-0282(02)03225-9. - DOI - PubMed
-
- Farquhar CM. The role of ovarian surgery in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:789–802. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources